CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 64 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,464,807 | $14,468,000 | 5.57% |
| COURAGE CAPITAL MANAGEMENT LLC | 192,486 | $1,130,000 | 0.86% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 90,455 | $531,000 | 0.07% |
| Alambic Investment Management, L.P. | 86,204 | $506,000 | 0.07% |
| Kalos Management, Inc. | 30,000 | $164,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 32,394 | $190,000 | 0.03% |
| ELLINGTON MANAGEMENT GROUP LLC | 60,600 | $356,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 55,008 | $323,000 | 0.02% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $129,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 580,972 | $3,411,000 | 0.02% |